Review
Osteogenesis imperfecta, diffuse idiopathic skeletal hyperostosis, and hypophosphatasia: one year in review 2025
G. De Mattia1, L. Pisapia2, C. Sgorbini3, M. Mazzantini4
- Rheumatology Unit, Department of Medical and Surgical Specialties, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Rheumatology Unit, Department of Medical and Surgical Specialties, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Rheumatology Unit, Department of Medical and Surgical Specialties, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Rheumatology Unit, Department of Medical and Surgical Specialties, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. mmazzant@int.med.unipi.it
CER18888
Review
Free to view
(click on article PDF icon to read the article)
Received: 03/05/2025
Accepted : 13/06/2025
In Press: 26/06/2025
Abstract
There are several metabolic bone diseases that rheumatologists should be aware of in clinical practice. In this paper, we reviewed the literature published in 2024 on osteogenesis imperfecta, diffuse idiopathic skeletal hyperostosis, and hypophosphatasia.